Blockchain Registration Transaction Record

Scinai Immunotherapeutics Reports $4.8 Million Net Gain in 2024

Scinai Immunotherapeutics reports significant financial gains in 2024, demonstrating success in the biopharma sector. Learn more about the company's revenue increase and growth potential.

Scinai Immunotherapeutics Reports $4.8 Million Net Gain in 2024

This news matters as it showcases the financial turnaround of Scinai Immunotherapeutics, highlighting its success in the biopharma sector. Investors and stakeholders can take note of the company's positive performance and growth potential.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xdd540bc406bdb9be9ae8b00fd6d8b7a46460957ece58bc8f7a2471c0585ac01b
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintfine8O_3-65d2a088632dfdcf46a04415ac51cead